These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1864907)
21. Development of a rapid and convenient method for determination of rubella virus-specific immunoglobulin G avidity. Vauloup-Fellous C; Ursulet-Diser J; Grangeot-Keros L Clin Vaccine Immunol; 2007 Nov; 14(11):1416-9. PubMed ID: 17913862 [TBL] [Abstract][Full Text] [Related]
22. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women. Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431 [TBL] [Abstract][Full Text] [Related]
23. Specific IgG subclass antibody in rubella virus infections. Thomas HI; Morgan-Capner P Epidemiol Infect; 1988 Jun; 100(3):443-54. PubMed ID: 3378586 [TBL] [Abstract][Full Text] [Related]
24. Differential IgG avidity to rubella virus structural proteins. Mauracher CA; Mitchell LA; Tingle AJ J Med Virol; 1992 Mar; 36(3):202-8. PubMed ID: 1564450 [TBL] [Abstract][Full Text] [Related]
25. [Microtiter enzyme-linked immunosorbent assay for rubella antibodies in human sera--analysis by parallel line assay method]. Morita M; Suzuki T; Suzuki Y; Hoshino H Kansenshogaku Zasshi; 1992 Aug; 66(8):1075-83. PubMed ID: 1402112 [TBL] [Abstract][Full Text] [Related]
26. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women]. Lafarga B; Noguera FJ; Pérez MC; Copado R; García A; Soria E Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628 [TBL] [Abstract][Full Text] [Related]
27. Recent rubella virus infection indicated by a low avidity of specific IgG. Hedman K; Seppälä I J Clin Immunol; 1988 May; 8(3):214-21. PubMed ID: 3292566 [TBL] [Abstract][Full Text] [Related]
28. Latex-agglutination test for rubella antibody: validity of positive results assessed by response to immunization and comparison with other tests. Storch GA; Myers N J Infect Dis; 1984 Mar; 149(3):459-64. PubMed ID: 6371155 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the subclasses and light chain types of IgG antibodies to rubella. Skvaril F; Schilt U Clin Exp Immunol; 1984 Mar; 55(3):671-6. PubMed ID: 6423327 [TBL] [Abstract][Full Text] [Related]
31. Detection of rubella virus specific IgM by fast protein liquid chromatography and enzyme-linked immunosorbent assay. Ho-Terry L; Cohen A; Terry GM J Med Microbiol; 1984 Apr; 17(2):177-80. PubMed ID: 6708083 [TBL] [Abstract][Full Text] [Related]
32. Significance of avidity and immunoblot analysis for rubella IgM-positive serum samples in pregnant women. Hofmann J; Liebert UG J Virol Methods; 2005 Dec; 130(1-2):66-71. PubMed ID: 16024097 [TBL] [Abstract][Full Text] [Related]
33. [Demonstration of Rubella-specific IgG and IgM antibody (sub) classes using the enzyme immunoassay (EIA)]. Doerr HW; Fleischer G; Wiesmann M Immun Infekt; 1984 Feb; 12(1):21-8. PubMed ID: 6398271 [TBL] [Abstract][Full Text] [Related]
34. Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations. Matter L; Kogelschatz K; Germann D J Infect Dis; 1997 Apr; 175(4):749-55. PubMed ID: 9086126 [TBL] [Abstract][Full Text] [Related]
35. Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey. Seker S; Abasiyanik MF; Salih BA Saudi Med J; 2004 May; 25(5):575-9. PubMed ID: 15138523 [TBL] [Abstract][Full Text] [Related]
36. The development of an M antibody capture ELISA for rubella IgM. Bellamy K; Rousseau SA; Gardner PS J Virol Methods; 1986 Nov; 14(3-4):243-51. PubMed ID: 3539958 [TBL] [Abstract][Full Text] [Related]
37. [Rubella virus IgG and IgM antibody levels in 17-20 year old female students using ELISA and fluorescent antibody tests]. Kocabeyoğlu O; Gün H; Yilmaz E; Güngör S; Emekdaş G; Yücel N Mikrobiyol Bul; 1988 Jan; 22(1):36-44. PubMed ID: 3078789 [TBL] [Abstract][Full Text] [Related]
39. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years. Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673 [TBL] [Abstract][Full Text] [Related]
40. Humoral immune response after primary rubella virus infection and after vaccination. Vauloup-Fellous C; Grangeot-Keros L Clin Vaccine Immunol; 2007 May; 14(5):644-7. PubMed ID: 17344342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]